Routinely collected real-world data in Danish population-based administrative and health registries and databases provide unique opportunities not only for assessment of risks and benefits of treatments, but also for studying disease courses, biomarkers, and drug discovery. Presentations and concrete examples.
The webinar is the fourth episode out of a four part webinar series on personalized medicine – from fundamental research to post-marketing activities. Each episode will provide an overview of the Danish research infrastructure within a specific phase of the drug development process and an opportunity for virtual meetings with leading Danish researchers and physicians as well as key officials from public health data organizations, including biobanks, health data, clinical and technology research.